Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stanford Biologists Watch RNA Fold in Real Time

Published: Monday, October 22, 2012
Last Updated: Monday, October 22, 2012
Bookmark and Share
Using optical tweezers and sub-nanoscale precision, Steven Block and Kirsten Frieda follow the process – and the consequences – of RNA folding.

In a soundproofed, vibration-stabilized, temperature-controlled room, Stanford biophysicist Steven Block was watching a very small origami project.

"The apparatus is so sensitive that, if you talk in the room, the vibrations in the air disturb the movement you're trying to measure," he said quietly. On a black-and-white monitor, two microscopic plastic beads were being slowly drawn apart.

Although we couldn't see it even at this high level of magnification, between the beads was stretched a single strand of RNA, folding up in real time.

Because RNA nucleotides are so small – each is only nanometers long – these effects had never been directly observed before. The Block Lab apparatus is so precise, it can measure distances to within the diameter of a hydrogen atom.

But Block's feat isn't remarkable only for its sensitivity. How RNA molecules fold is a longstanding biological problem. It's crucial for the molecules' function, and different RNA configurations play a fundamental regulatory role during the transcription of those very RNA molecules.

"Issues of gene control are arguably more important than the genes themselves," Block said. "What differentiates organisms are not the genes per se, it's which genes get expressed where and when."
Block, a professor of applied physics and of biology, and graduate student Kirsten Frieda published their findings today in the journal Science.

Laser traps

The key to the "tour-de-force of instrumentation," as Block punned, was the use of "optical tweezers." When placed in the path of a highly focused laser, the team's tiny beads were attracted to the center of the beam, where the electric field produced by the light is strongest. The researchers were thereby able to position and immobilize the beads with extreme consistency and accuracy.

In Block's elegant setup, a single molecule of RNA polymerase – the enzyme that transcribes DNA strands into RNA – was attached to one bead, while the emerging RNA transcript was linked to the other.

By keeping the tension between the two beads constant and measuring the distance between them as they moved apart, Block was able to gauge the changing length of the new RNA strand.

"What we got was a blow-by-blow readout of how RNA folds as it is processed by RNA polymerase," said Block.

Switching the riboswitch

In the case of the RNA transcript studied by Block and Frieda, there were two conformation options, which led to two very different functional results.

The "favored" option – about 10 billion times more likely to form, all things being equal – was a terminator structure that would stop transcription if it formed.

The other structure was an anti-terminator formed by an RNA element known as a riboswitch located a little upstream of the terminator. Riboswitches are a common but poorly understood method of gene regulation, found in all kingdoms of life. These stretches of RNA transcripts change conformation after binding certain small target molecules, with consequences for gene control.

The anti-terminator was less thermodynamically stable than the terminator, and therefore much less likely to form. Because it formed slightly more quickly than the terminator, however, "it got its foot in the door," said Block.

"It's a bit like the old joke about escaping a bear in the woods," he said. "You don't actually have to run more quickly than the bear, you just have to run faster than your friend who's with you."

When the riboswitch's target molecule was present, the researchers found, the anti-terminator would consistently form, preventing the terminator from folding and allowing transcription to continue onward. The anti-terminator would only hold its shape for a second or so, but a second is just long enough.
"We were the first to actually see a riboswitch switch," Block said.

The team hopes to extend its techniques to other structured RNAs, including more riboswitches, as well as ribozymes – RNAs that can catalyze chemical reactions – and the tRNAs crucial to protein translation.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Wednesday, July 06, 2016
Guided Chemotherapy Missiles to Target Cancer Cells
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
Tuesday, July 05, 2016
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Monday, June 20, 2016
Paper Published Based on RNA Game
Video-gamers have co-authored a paper describing a new set of rules for determining the difficulty of designing structures composed of RNA molecules.
Thursday, February 18, 2016
Flexible Gene Expression May Regulate Social Status
Scientists show how the selective expression of genes through epigenetics can regulate the social status of African cichlid fish.
Monday, January 11, 2016
U.S. Needs a New Approach for Governance of Risky Research
The United States needs better oversight of risky biological research to reduce the likelihood of a bioengineered super virus escaping from the lab or being deliberately unleashed, according three Stanford scholars.
Monday, January 04, 2016
Accelerating Protein Evolution
A new tool enables researchers to test millions of mutated proteins in a matter of hours or days, speeding the search for new medicines, industrial enzymes and biosensors.
Monday, December 14, 2015
Gene Linked to Heart Failure
Researchers have identified a previously unknown association between heart function and the narcolepsy-linked orexin receptor pathway, a finding that could provide a promising direction for treatment research.
Wednesday, December 02, 2015
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Thursday, November 26, 2015
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Wednesday, November 25, 2015
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Thursday, September 24, 2015
Key Mechanism in Gene Expression Discovered
RNA polymerase II makes life possible by expressing genes. Now, a team of Stanford biologists, chemists and applied physicists has observed it at work in real time.
Thursday, September 17, 2015
Scientists Home In On Origin Of Human, Chimpanzee Facial Differences
A study of species-specific regulation of gene expression in chimps and humans has identified regions important in human facial development and variation.
Monday, September 14, 2015
Identifying Defective Heart Genes
A new technique could eventually enable doctors to diagnose genetic heart diseases by rapidly scanning more than 85 genes known to cause cardiac anomalies.
Thursday, August 13, 2015
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Monday, July 27, 2015
Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!